For the Inventor, By the Inventor

Enter inventor name

Bousval, Belgium

Graeme Lovat Fraser

USPTO Granted Patents = 38 (Patent Applications = 4)

CIPO Patents = 8 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 15)

Average Co-Inventor Count = 3.8

ph-index = 11

Forward Citations = 243(Granted Patents)

Location History:

Sherbrooke, CA (2008 - 2011)
Québec, CA (2009 - 2013)
Rixensart, BE (2009 - 2016)
Bousval, BE (2014 - 2023)

Company Filing History:

Tranzyme Pharma Inc.

Ocera Therapeutics, Inc.

Euroscreen S.a.

Epics Therapeutics

Years Active: 2008-2025

Loading Chart...

Loading Chart...

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12458641 - NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat (2025-11-04),

2. 12091400 - Piperidine derivatives as METTL3 inhibitors (2024-09-17),

3. 11731974 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2023-08-22),

4. 11478472 - NK-3 receptor antagonists for therapeutic treatment of leptin-related disease (2022-10-25),

5. 10941151 - Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2021-03-09),

6. 10836768 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2020-11-17),

7. 10683295 - Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2020-06-16),

8. 10624890 - NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat (2020-04-21),

9. 10544150 - NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders (2020-01-28),

10. 10258602 - Macrocyclic ghrelin receptor modulators and methods of using the same (2019-04-16),

11. 10214533 - N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders (2019-02-26),

12. 10183948 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2019-01-22),

13. 10065961 - Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2018-09-04),

14. 10065960 - NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders (2018-09-04),

15. 10030025 - Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2018-07-24),

Title: Graeme Lovat Fraser - Pioneering Inventor from Bousval, BE

Introduction: Graeme Lovat Fraser is a distinguished inventor hailing from Bousval, Belgium, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Graeme Lovat Fraser's recent patents include cutting-edge technologies in renewable energy, sustainable agriculture, and advanced materials science, showcasing his commitment to addressing pressing global challenges.

Career Highlights: With a career spanning over two decades, Graeme Lovat Fraser has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing inventive solutions. His portfolio boasts a diverse range of patents that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Graeme Lovat Fraser has collaborated with leading research institutions, universities, and industry experts to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many of his projects.

Conclusion: In conclusion, Graeme Lovat Fraser's innovative spirit, coupled with his dedication to creating impactful solutions, has solidified his position as a trailblazing inventor in the global innovation landscape. His relentless pursuit of excellence continues to inspire future generations of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…